INNOVATION PHARMACEUTICALS INC. (IPIX)
Clinical trial NCT06979726 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-03-31 → 2026-11-30
Clinical trial NCT06979726 updates: 1. completion date: 2026-05-01 → 2026-12-31 2. primary completion date: 2026-03-31 → 2026-11-30
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical